Immunitybio Inc (IBRX)

EBITDA Margin

-538.46%

TTM · Period ending:

IBRX logo

IBRX EBITDA Margin

Latest reported-538.46%
IBRX TTM EBITDA Margin (-192761.98% → -538.46%)
High-resolution chart · PNG

IBRX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Immunitybio Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-538.4578%
-515.189%
-197.3351%
-281.8012%
-420.3763%
-863.3367%
-1,831.0071%
-5,818.6852%
-33,764.8318%
-149,596.3576%
-70,175.2412%
-56,521.0432%
-58,544.7635%
-55,297.099%
-137,393.75%
-60,804.4883%
-65,623.1683%
-41,343.2633%
-34,341.7559%
-47,218.7611%
-38,115.0769%
-28,417.2691%
-21,992.3674%
-9,548.3254%
-7,236.2688%
-7,152.5135%
-6,549.1614%
-141,139.0244%
-108,885%
-160,878.7234%
-184,555.3191%
-183,194.2308%
-333,231.0345%
-239,243.5897%
-201,626.6667%
-191,887.234%
-194,358.8235%
-226,095.9184%
-267,456.8182%
-390,654.5455%
-436,576.1905%
-192,761.9835%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.